Dare Bioscience, Inc. (DARE) Shareholders’ equity 2012–2025
Dare Bioscience, Inc. (DARE) shareholders’ equity at each fiscal year-end, per SEC filings.
$2.8MFY2025 · since FY2012: -$80.0M → $2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.8M | +147.3% |
| FY2024 | -$6.0M | -19.1% |
| FY2023 | -$5.0M | -145.4% |
| FY2022 | $11.1M | -71.3% |
| FY2021 | $38.8M | — |
| FY2016 | -$710,621 | — |
| FY2014 | $45.3M | +148.1% |
| FY2013 | -$94.3M | -17.8% |
| FY2012 | -$80.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice